Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

27 February 2008

Hospital costs of managing deliberate self-poisoning in Turkey

Mustafa SerinkenABCDEF, Ozgur KarciogluADEF, Cem SengulABCD, Ibrahim TurkcuerBEF, Mustafa Kemal KeysanBD

Med Sci Monit 2008; 14(3): CR152-158 :: ID: 836581

Abstract

Background
Most published data on the characteristics and direct hospital costs of deliberate self-poisoning (DSP) were collected from developed countries. This study was conducted to investigate hospital costs of DSP cases and relevant factors in a university-based emergency department (ED) in Turkey.
Material and Method
All patients referred to the ED due to DSP in the one-year period between October 1, 2005, and September 30, 2006, were investigated prospectively. Clinical and demographic features were analyzed.
Results
The female-to-male ratio was 6.3 (189/30). Mean age of the patients was 24.5+/-5.7 years. Medical drugs comprised 93.6% (n=205) of the substances ingested in admissions due to DSP. The mean cost of patients with DSP was calculated to be $144.06+/-90.83. Treatment costs constituted 36.2% of the total figure ($52.27). Total costs showed statistically significant differences with respect to sex, type of intoxicants, and location of treatment. Venipuncture, monitoring, nasogastric tube insertion, and gastric lavage were the procedures most commonly applied. Activated charcoal was administered to 66.9% (n=146) of the study sample.
Conclusions
The study sample had many differences in demographic and clinical outcomes of patients with DSP as well as hospital costs compared with global reports. Gender, ingestion of non-medical substances, and treatment location affected the total hospital costs of these patients. Strategies focusing on high-risk subgroups and conditions may help to reduce unnecessary expenses.

Keywords: Sex Distribution, Poison Control Centers - economics, Turkey, Suicide, Attempted - economics, Cost-Benefit Analysis, Age Distribution, Adolescent

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750